| Literature DB >> 31589352 |
Jesse Mez1,2,3, Daniel H Daneshvar1,4, Bobak Abdolmohammadi1,2, Alicia S Chua1,5, Michael L Alosco1,2, Patrick T Kiernan1,2,6, Laney Evers1,2, Laura Marshall1,2, Brett M Martin1,7, Joseph N Palmisano1,7, Christopher J Nowinski1,8, Ian Mahar1,2, Jonathan D Cherry1,9,10, Victor E Alvarez1,9,10, Brigid Dwyer2,11, Bertrand R Huber1,2,9,10, Thor D Stein1,3,9,10,12, Lee E Goldstein1,2,12,13,14, Douglas I Katz2,11, Robert C Cantu1,2,8,15,16, Rhoda Au1,3,17,18, Neil W Kowall1,2,9,12, Robert A Stern1,2,15,17, Michael D McClean19, Jennifer Weuve18, Yorghos Tripodis1,5, Ann C McKee1,2,3,9,10,12.
Abstract
OBJECTIVE: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with exposure to contact and collision sports, including American football. We hypothesized a dose-response relationship between duration of football played and CTE risk and severity.Entities:
Year: 2019 PMID: 31589352 PMCID: PMC6973077 DOI: 10.1002/ana.25611
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 10.422
Figure 1Flowchart showing participant inclusion. Curved arrows indicate excluded participants. Of the 155 donors enrolled between 2008 and 2013, 92 (81 with CTE, 11 without CTE) were included in the analytic set. Of the 249 donors enrolled between 2014 and 2017, 163 (142 with CTE, 21 without CTE) were included in the final analytic set. CTE = chronic traumatic encephalopathy; FHS: Framingham Heart Study; VA‐BU‐CLF: Veterans Affairs–Boston University–Concussion Legacy Foundation.
Demographic, American Football Exposure and Neuropathological Characteristics of 266 Players Stratified by CTE Status
| Characteristic | No CTE (%) (n = 43) | Mild CTE (%) (n = 78) | Severe CTE (%) (n = 145) | All (%) (n = 266) |
|---|---|---|---|---|
| Sex | ||||
| Men | 43 (100%) | 78 (100%) | 145 (100%) | 266 (100%) |
| Women | 0 | 0 | 0 | 0 |
| Race | ||||
| White | 37 (86%) | 66 (85%) | 114 (79%) | 217 (82%) |
| Black | 4 (10%) | 11 (14%) | 30 (20%) | 45 (17%) |
| Pacific Islander | 0 | 0 | 1 (1%) | 1 (<1%) |
| Asian | 1 (2%) | 0 | 0 | 1 (<1%) |
| Other | 1 (2%) | 0 | 0 | 1 (<1%) |
| Unknown | 0 | 1 (1%) | 0 | 1 (<1%) |
| Mean age at death (SD) | 57.0 (23.1) | 48.9 (19.8) | 68.7 (12.9) | 61.0 (19.2) |
| Cause of death | ||||
| Neurodegenerative | 8 (19%) | 11 (14%) | 66 (46%) | 85 (32%) |
| Cardiovascular disease | 8 (19%) | 10 (13%) | 29 (20%) | 47 (18%) |
| Suicide | 6 (14%) | 21 (27%) | 6 (4%) | 33 (12%) |
| Cancer | 5 (12%) | 5 (6%) | 11 (8%) | 21 (8%) |
| Motor neuron disease | 2 (4%) | 5 (6%) | 9 (6%) | 16 (6%) |
| Accidental overdose | 3 (7%) | 4 (5%) | 5 (3%) | 12 (4%) |
| Injury | 2 (4%) | 2 (3%) | 4 (3%) | 8 (3%) |
| Other | 8 (19%) | 20 (26%) | 15 (10%) | 43 (16%) |
| Unknown | 1 (2%) | 0 | 0 | 1 (<1%) |
| Median concussion count (IQR)b | ||||
| Concussion definition provided (n=162) | 10.0 (0‐65) | 90.0 (12.5‐200) | 40.0 (12‐125) | 47.5 (12‐150) |
| No concussion definition provided (n=85) | 4.5 (0‐9.25) | 3.0 (1‐8.5) | 8.0 (1.5‐18.5) | 5 (1‐10) |
| Mean AFE to football in years (SD) | 12.0 (3.2) | 11.3 (3.1) | 12.2 (2.7) | 11.9 (2.9) |
| Mean duration played in years (SD) | 7.3 (4.3) | 11.6 (4.9) | 15.6 (5.6) | 13.1 (6.0) |
Includes dementia‐related and parkinsonian‐related causes of death.
Beginning in January 2014, participants were read a definition of concussion prior to inquiry.
AFE = age of first exposure.
Demographic, American Football Exposure and Neuropathological Characteristics of 266 Players Stratified by CTE Status
| Characteristic | No CTE (%) (n = 43) | Mild CTE (%) (n = 78) | Severe CTE (%) (n = 145) | All (%) (n = 266) |
|---|---|---|---|---|
| Highest level of play | ||||
| Youth | 1 (2%) | 3 (4%) | 1 (1%) | 5 (2%) |
| High school | 20 (47%) | 12 (15%) | 2 (2%) | 34 (13%) |
| College | 14 (33%) | 30 (38%) | 37 (25%) | 81 (30%) |
| Semi‐Professional | 5 (12%) | 4 (5%) | 1 (1%) | 10 (4%) |
| Professional (NFL, CFL) | 3 (6%) | 29 (37%) | 104 (71%) | 136 (51%) |
| Primary position at highest level of play | ||||
| Offensive Lineman | 9 (20%) | 15 (19%) | 33 (23%) | 57 (21%) |
| Defensive Lineman | 6 (14%) | 17 (22%) | 29 (20%) | 52 (20%) |
| Running Back | 5 (12%) | 10 (13%) | 27 (19%) | 42 (16%) |
| Linebacker | 2 (4%) | 13 (17%) | 15 (10%) | 30 (11%) |
| Defensive Back | 5 (12%) | 9 (12%) | 21 (14%) | 35 (13%) |
| Quarterback | 5 (12%) | 4 (5%) | 11 (8%) | 20 (8%) |
| Tight End | 5 (12%) | 3 (4%) | 6 (4%) | 14 (5%) |
| Wide Receiver | 1 (2%) | 3 (4%) | 1 (1%) | 5 (2%) |
| Kicker or Punter | 0 | 2 (2%) | 0 | 2 (1%) |
| Unknown/Unreported | 5 (12%) | 2 (3%)c | 2 (1%) | 9 (3%) |
| Military veterans | 16 (37%) | 15 (19%) | 43 (30%) | 74 (28%) |
| Other contact sport play | 13 (30%) | 23 (30%) | 23 (16%) | 59 (22%) |
| Neuropathology | ||||
| Alzheimer's disease | 8 (19%) | 2 (3%) | 26 (18%) | 36 (14%) |
| Lewy body disease | 8 (19%) | 7 (9%) | 34 (23%) | 49 (18%) |
| Frontotemporal lobar degeneration | 5 (12%) | 9 (12%) | 12 (8%) | 26 (10%) |
| Motor neuron disease | 1 (2%) | 5 (6%) | 9 (6%) | 15 (6%) |
Both players played other positions, but kicker/punter was the primary position.
CFL = Canadian Football League; NFL = National Football League.
Demographic, American Football Exposure and Neuropathological Characteristics of 266 Players Stratified by Brain Bank
| Characteristic | VA‐BU‐CLF pre‐2014 (%) (n = 91) | VA‐BU‐CLF 2014‐2017 (%) (n = 164) | FHS (%) (n = 11) | All (%) (n = 266) |
|---|---|---|---|---|
| Sex | ||||
| Men | 91 (100%) | 164 (100%) | 11 (100%) | 266 (100%) |
| Women | 0 | 0 | 0 | 0 |
| Race | ||||
| White | 79 (87%) | 127 (77%) | 11 (100%) | 217 (82%) |
| Black | 11 (12%) | 34 (20%) | 0 | 45 (17%) |
| Pacific Islander | 0 | 1 (1%) | 0 | 1 (<1%) |
| Asian | 0 | 1 (1%) | 0 | 1 (<1%) |
| Other | 0 | 1 (1%) | 0 | 1 (<1%) |
| Unknown | 1 (1%) | 0 | 0 | 1 (<1%) |
| Mean age at death (SD) | 58.4 (18.9) | 61.0 (19.0) | 82.2 (9.9) | 61.0 (19.2) |
| Cause of death | ||||
| Neurodegenerative | 26 (28%) | 58 (35%) | 1 (9%) | 85 (32%) |
| Cardiovascular disease | 12 (13%) | 31 (19%) | 4 (36%) | 47 (18%) |
| Suicide | 14 (15%) | 19 (12%) | 0 | 33 (12%) |
| Cancer | 9 (10%) | 8 (5%) | 4 (36%) | 21 (8%) |
| Motor neuron disease | 10 (11%) | 6 (4%) | 0 | 16 (6%) |
| Accidental overdose | 6 (7%) | 6 (4%) | 0 | 12 (4%) |
| Injury | 6 (7%) | 2 (1%) | 0 | 8 (3%) |
| Other | 7 (8%) | 34 (20%) | 2 (18%) | 43 (16%) |
| Unknown | 1 (1%) | 0 | 0 | 1 (<1%) |
| Median concussion count (IQR) | ||||
| Concussion definition provided | ‐ | 45 (12‐150) | 0 | 47.5 (12‐150) |
| No concussion definition provided | 5 (1‐10) | ‐ | ‐ | 5 (1‐10) |
| Mean AFE to football in years (SD) | 11.8 (2.6) | 11.8 (3.1) | 14.3 (2.4) | 11.9 (2.9) |
| Mean duration played in years (SD) | 13.0 (6.1) | 13.7 (5.8) | 4.6 (1.3) | 13.1 (6.0) |
Includes dementia‐related and parkinsonian‐related causes of death.
Beginning in January 2014, participants were read a definition of concussion prior to inquiry.
AFE = age of first exposure.
Demographic, American Football Exposure and Neuropathological Characteristics of 266 Players Stratified by Brain Bank
| Characteristic | VA‐BU‐CLF pre‐2014 (%) (n = 91) | VA‐BU‐CLF 2014‐2017 (%) (n = 164) | FHS (%) (n = 11) | All (%) (n = 266) |
|---|---|---|---|---|
| Highest level of play | ||||
| Youth | 2 (2%) | 2 (1%) | 1 (9%) | 5 (2%) |
| High school | 16 (18%) | 12 (7%) | 6 (55%) | 34 (13%) |
| College | 20 (22%) | 57 (35%) | 4 (36%) | 81 (30%) |
| Semi‐Professional | 4 (4%) | 6 (4%) | 0 | 10 (4%) |
| Professional (NFL, CFL) | 49 (54%) | 87 (53%) | 0 | 136 (51%) |
| Primary position at highest level of play | ||||
| Offensive Lineman | 20 (21%) | 34 (21%) | 3 (27%) | 57 (21%) |
| Defensive Lineman | 20 (21%) | 32 (20%) | 0 | 52 (20%) |
| Running Back | 8 (9%) | 31 (19%) | 3 (27%) | 42 (16%) |
| Linebacker | 11 (12%) | 19 (12%) | 0 | 30 (11%) |
| Defensive Back | 14 (15%) | 21 (13%) | 0 | 35 (13%) |
| Quarterback | 5 (6%) | 13 (7%) | 2 (18%) | 20 (8%) |
| Tight End | 6 (7%) | 7 (4%) | 1 (9%) | 14 (5%) |
| Wide Receiver | 3 (4%) | 2 (1%) | 0 | 5 (2%) |
| Kicker or Punter | 1 (1%) | 1 (1%) | 0 | 2 (1%) |
| Unknown/Unreported | 3 (4%) | 4 (2%) | 2 (18%) | 9 (3%) |
| Military veterans | 19 (21%) | 47 (29%) | 8 (73%) | 74 (28%) |
| Other contact sport play | 20 (22%) | 36 (22%) | 3 (27%) | 59 (22%) |
| Neuropathology | ||||
| Alzheimer's disease | 10 (11%) | 22 (13%) | 4 (36%) | 36 (14%) |
| Lewy body disease | 15 (17%) | 29 (18%) | 5 (45%) | 49 (18%) |
| Frontotemporal lobar degeneration | 10 (11%) | 15 (9%) | 1 (9%) | 26 (10%) |
| Motor neuron disease | 9 (10%) | 5 (3%) | 1 (9%) | 15 (6%) |
Both players played other positions, but kicker/punter was the primary position.
CFL = Canadian Football League; NFL = National Football League.
Figure 2Distribution of duration played and representative images of chronic traumatic encephalopathy (CTE) status and CTE severity. (A) Violin plots of duration played stratified by CTE status. The colored areas show the distribution of duration played. The interior boxplots show the median, lower and upper quartiles, and 95% confidence intervals. (B, C) Ten‐micrometer paraffin‐embedded tissue sections were immunostained with microscopic mouse monoclonal antibody for phosphorylated tau (AT8; Pierce Endogen, Waltham, MA) and counterstained with hematoxylin. Positive p‐tau immunostaining appears dark red. (B) Normal blood vessel at the sulcal depth with no CTE pathology. (C) CTE perivascular lesion: neurofibrillary tangles and dotlike and threadlike neurites surround a small blood vessel at the sulcal depth. (D) Violin plots of duration played stratified by CTE severity among participants with CTE. The colored areas show the distribution of duration played. The interior boxplots show the median, lower and upper quartiles, and 95% confidence interval. (E, F) Fifty‐micrometer hemispheric tissue sections immunostained with mouse monoclonal antibody CP‐13, directed against tau phosphoserine 202 (courtesy of Peter Davies, PhD, Feinstein Institute for Medical Research; 1:200). (E) Mild CTE pathology with multiple perivascular p‐tau CTE lesions at depths of sulci of the frontal cortex without neurofibrillary degeneration in the medial temporal lobe. (F) Severe CTE pathology with multiple large CTE lesions in the frontal cortex and insula, and diffuse neurofibrillary degeneration in the medial temporal lobe.
Figure 3Evaluating the linearity assumption. (A) Locally estimated scatterplot smoothing (LOESS) regression plot of the log odds of the predicted probability of chronic traumatic encephalopathy (CTE) status by duration played. The plot appears visually to be relatively linear. (B) LOESS regression plot of the log odds of the predicted probability of CTE severity by duration played among participants diagnosed with CTE. The plot appears visually to be relatively linear. (C) Plot of the residuals by predicted values for the duration played–neurofibrillary tangle (NFT) burden linear regression model. The plot appears randomly scattered.
Figure 4Receiver operating characteristic curve using duration played to classify chronic traumatic encephalopathy (CTE) status. Thresholds of duration played that corresponded to negative and positive likelihood ratios (LR−, LR+, respectively) closest to 0.1 and 10 were 4.5 years and 14.5 years, respectively. Diagnostic tests with these likelihood ratios may produce sizable and often conclusive shifts from pre‐ to post‐test probability.42 CTE classification sensitivity and specificity were maximized together at approximately 11 years played. AUC = area under the curve.
Figure 5Evaluating selection bias. (A) Factors and their associations with the relative odds of brain donation status from a community‐based aging cohort that were included in the selection model (adapted from Haneuse et al12). Both education level and sex also predicted brain donation, but were excluded from the selection model because there were no women in this study and because education quality differs markedly for college and professional football players. OR = odds ratio. (B) Simplified directed acyclic graph demonstrating the relationship between duration of American football play, chronic traumatic encephalopathy (CTE) pathology, and brain bank selection. Brain bank selection will only bias the relationship between duration of American football play and CTE pathology (dotted blue arrow) if both duration played (or a cause of duration played) and CTE pathology (or a cause of CTE pathology) are related to brain bank selection. (C) Simulation analyses assessed how a range of non‐negative values for selection parameters for duration played (, ie, log odds of brain donation for each additional year played when CTE pathology is absent), CTE disease status (, ie, log odds of brain donation when CTE pathology is present compared with absent when duration played is approaching zero), and the duration played × CTE status cross product (, ie, additional log odds of brain donation for each additional year played beyond , when CTE pathology is present) would affect the odds ratio for the relationship between duration played and CTE disease status. (D, E) Similar simulation analyses assessed how a range of non‐negative values for selection parameters would affect (D) the odds ratio for the relationship between duration played and CTE severity, and (E) the relationship between duration played and neurofibrillary tangle (NFT) burden. SD = standard deviation.
Primary and Sensitivity Analyses Assessing the Relationship between Duration Played and CTE Neuropathology
| Outcome | Effect Size (95% CI) |
|---|---|
| Primary analyses | |
| (A) Relationship between duration played and CTE neuropathology | |
| (1) CTE status (n = 223 with CTE, 43 without CTE), duration, per year | OR of having CTE: 1.30 (1.19–1.41) |
| (2) CTE severity (n = 223 with CTE), duration, per year | OR of having severe CTE: 1.14 (1.07–1.22) |
| (3) NFT burden (n = 172 with CTE), duration, per year | Standardized units higher in NFT burden: 0.05 (0.03–0.07) |
| Sensitivity analyses | |
| (B) Relationship between duration played and CTE neuropathology in participants who played no contact sports besides football | |
| (1) CTE status (n = 177 with CTE, 30 without CTE), duration, per year | OR of having CTE: 1.33 (1.19–1.48) |
| (2) CTE severity (n = 177 with CTE), duration, per year | OR of having severe CTE: 1.14 (1.05–1.23) |
| (3) NFT burden (n = 138 with CTE), duration, per year | Standardized units higher in NFT burden: 0.06 (0.03–0.08) |
| (C) Relationship between duration played and CTE neuropathology in participants with no comorbid neurodegenerative disease | |
| (1) CTE status (n = 134 with CTE, 27 without CTE), duration, per year | OR of having CTE: 1.21 (1.10–1.33) |
| (2) CTE severity (n = 134 with CTE), duration, per year | OR of having severe CTE: 1.18 (1.08–1.29) |
| (3) NFT burden (n = 101 with CTE), duration, per year | Standardized units higher in NFT burden: 0.05 (0.02–0.08) |
| (D) Relationship between duration played and CTE neuropathology in participants from the VA‐BU‐CLF Brain Bank prior to 2014 | |
| (1) CTE status (n = 81 with CTE, 11 without CTE), duration, per year | OR of having CTE: 1.26 (1.08–1.47) |
| (2) CTE severity (n = 81 with CTE), duration, per year | OR of having severe CTE: 1.07 (0.97–1.18) |
| (3) NFT burden (n = 49 with CTE), duration, per year | Standardized units higher in NFT burden: 0.06 (0.02–0.10) |
| (E) Relationship between duration played and CTE neuropathology in participants from the VA‐BU‐CLF Brain Bank from 2014 to 2017 | |
| (1) CTE status (n = 142 with CTE, 21 without CTE), duration, per year | OR of having CTE: 1.24 (1.11–1.39) |
| (2) CTE severity (n = 142 with CTE), duration, per year | OR of having severe CTE: 1.21 (1.09–1.33) |
| (3) NFT burden (n = 123 with CTE), duration, per year | Standardized units higher in NFT burden: 0.05 (0.03–0.07) |
Separate models were run for each outcome. Models were adjusted for age at death.
Fifty‐one participants had missing NFT data from at least 1 of 11 brain regions and were excluded.
CI = confidence interval; CTE = chronic traumatic encephalopathy; NFT = neurofibrillary tangle; OR = odds ratio; VA‐BU‐CLF = Veterans Affairs–Boston University–Concussion Legacy Foundation.